Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Buy

Price to Earnings Rating

Sell

Analyst Rating

Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Sell

C

Decibel Therapeutics, Inc. Common Stock (DBTX)

Pharmaceutical Preparations

https://www.decibeltx.com

Decibel Therapeutics Inc is a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments for hearing and balance disorders. It aims to restore and improve hearing and balance through the restoration and regeneration of functional hair cells and non-sensory support cells within the inner ear. Its lead gene therapy product candidate is DB-OTO which provides hearing to individuals born with profound hearing loss due to an OTOF deficiency. The firm's pipeline products comprise DB-ATO, AAV.103, AAV.104, AAV.201, DB-020, and Cochlear Hair Cell Regeneration.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

02/12/2021

Market Cap

123,373,079

Shares Outstanding

25,130,000

Weighted SO

25,126,935

Total Employees

N/A

Upcoming Earnings

11/08/2023

Similar Tickers

HOWL --.--%

HOWL --.--%

EWTX --.--%

CELC --.--%

CCCC --.--%

AVTE --.--%

ADAG --.--%

ADAG --.--%

ACRV --.--%

Beta

-0.4025

Last Div

0.0000

Range

1.61-5.4

Chg

-0.0400

Avg Vol

214738

Mkt Cap

123373079

Exch

NASDAQ

Country

US

Phone

617 370 8701

DCF Diff

N/A

DCF

0.0000

Div Yield

0.0000

P/S

0.0000

EV Multiple

-1.4925

P/FV

2.3041

Div Yield %

0.0000

P/E

-1.9377

PEG

0.3294

Payout

0.0000

Current Ratio

3.0269

Quick Ratio

2.9460

Cash Ratio

1.4976

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

0.0000

CCC

0.0000

Gross Margin

0.0000

Op Margin

0.0000

Pretax Margin

0.0000

Net Margin

0.0000

Eff Tax Rate

-0.0045

ROA

-0.6716

ROE

-0.8403

ROCE

-0.9733

NI/EBT

1.0045

EBT/EBIT

0.9562

EBIT/Rev

0.0000

Debt Ratio

0.1361

D/E

0.2410

LT Debt/Cap

0.1470

Total Debt/Cap

0.1942

Int Coverage

-237.3993

CF/Debt

-3.7991

Equity Multi

1.7705

Rec Turnover

0.0000

Pay Turnover

0.0000

Inv Turnover

0.0000

FA Turnover

0.0000

Asset Turnover

0.0000

OCF/Share

-1.9509

FCF/Share

-1.9707

Cash/Share

3.1298

OCF/Sales

0.0000

FCF/OCF

1.0102

CF Coverage

-3.7991

ST Coverage

-13.3243

CapEx Coverage

-98.4012

Div&CapEx Cov

-98.4012

P/BV

2.3041

P/B

2.3041

P/S

0.0000

P/E

-1.9377

P/FCF

-2.5023

P/OCF

-2.5168

P/CF

-2.5168

PEG

0.3294

P/S

0.0000

EV Multiple

-1.4925

P/FV

2.3041

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation